
Endomimetics™ Awarded $2.8 Million Phase II SBIR Grant to Develop and Evaluate the Potential of Bionanomatrix™ to Improve ...
BIRMINGHAM, Ala., Sept. 17, 2024 (GLOBE NEWSWIRE) -- Endomimetics, the developer of Bionanomatrix™, a peptide-based biomaterial to promote healing and improve outcomes following medical device implantation and other procedures, today announced the …